T. Rowe Price Associates
ERAS icon

T. Rowe Price Associates’s Erasca ERAS Stock Holding History

T. Rowe Price Associates’s Portfolio ERAS Stock Details ERAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$29.4M Buy
1,815,340
+1,711,837
+1,654% +$20.2M ﹤0.01% 937
2025
Q4 		$386K Buy
103,503
+9,923
+11% +$27.9K ﹤0.01% 2509
2025
Q3 		$205K Buy
93,580
+7,112
+8% +$11.3K ﹤0.01% 2785
2025
Q2 		$110K Buy
86,468
+10,195
+13% +$13.6K ﹤0.01% 2876
2025
Q1 		$105K Buy
76,273
+6,236
+9% +$10.7K ﹤0.01% 2809
2024
Q4 		$176K Buy
70,037
+10,899
+18% +$29.9K ﹤0.01% 2732
2024
Q3 		$162K Buy
59,138
+22,993
+64% +$64.8K ﹤0.01% 2717
2024
Q2 		$86K Buy
36,145
+11,461
+46% +$24.7K ﹤0.01% 2776
2024
Q1 		$51K Buy
24,684
+4,753
+24% +$9.5K ﹤0.01% 2869
2023
Q4 		$43K Buy
19,931
+2,250
+13% +$4.75K ﹤0.01% 2830
2023
Q3 		$35K Buy
17,681
+2,224
+14% +$5.7K ﹤0.01% 2814
2023
Q2 		$43K Buy
15,457
+829
+6% +$2.36K ﹤0.01% 2819
2023
Q1 		$45K Buy
14,628
+4,112
+39% +$15K ﹤0.01% 2802
2022
Q4 		$45K Buy
10,516
+470
+5% +$3.19K ﹤0.01% 2823
2022
Q3 		$79K Buy
+10,046
New +$80.9K ﹤0.01% 2776

Other funds holding ERAS

FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return

T. Rowe Price Associates's ERAS Position: Q1 2026 in Review

T. Rowe Price Associates increased its Erasca (ERAS) stake by 1,654% in Q1 2026, buying an estimated $20.2M and bringing the position to 1,815,340 shares worth $29.4M. The position accounts for ﹤0.01% of the portfolio, ranked #937.

T. Rowe Price Associates first reported a position in ERAS in Q3 2022 and has held it in 15 quarters since. 225 funds tracked by Wall St. Rank hold ERAS as of Q1 2026.

  • T. Rowe Price Associates held 1,815,340 shares of Erasca worth $29.4M as of Q1 2026.
  • T. Rowe Price Associates bought 1,711,837 Erasca shares in Q1 2026, an estimated $20.2M.
  • Erasca made up ﹤0.01% of T. Rowe Price Associates's portfolio in Q1 2026, its #937 holding.
  • T. Rowe Price Associates first reported a position in Erasca in Q3 2022 and has held it in 15 quarters since.
  • 225 funds tracked by Wall St. Rank held Erasca as of Q1 2026.

Based on T. Rowe Price Associates's 13F filing for Q1 2026, filed 15 May 2026.